Scarica l'app Stockscreener
10.70
0.28%
0.03
Pre-mercato:
10.71
0.01
+0.09%
Precedente Chiudi:
$10.67
Aprire:
$10.72
Volume 24 ore:
149.59K
Relative Volume:
0.43
Capitalizzazione di mercato:
$187.82M
Reddito:
$1.54M
Utile/perdita netta:
$-38.70M
Rapporto P/E:
-2.2912
EPS:
-4.67
Flusso di cassa netto:
$-36.86M
1 W Prestazione:
-9.93%
1M Prestazione:
-4.89%
6M Prestazione:
+26.33%
1 anno Prestazione:
-33.33%
Intervallo 1D:
$10.50
$10.82
Intervallo di 1 settimana:
$10.05
$11.98
Portata 52W:
$4.64
$20.56
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Nome
Corbus Pharmaceuticals Holdings Inc
Settore
Industria
Telefono
617-963-0103
Indirizzo
500 RIVER RIDGE DRIVE, NORWOOD, MA
Confronta CRBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
10.70 | 187.29M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Ripresa | B. Riley Securities | Buy |
| 2025-02-28 | Iniziato | William Blair | Outperform |
| 2024-12-02 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Iniziato | Wedbush | Outperform |
| 2024-07-22 | Ripresa | H.C. Wainwright | Buy |
| 2024-06-26 | Iniziato | B. Riley Securities | Buy |
| 2024-06-03 | Reiterato | Oppenheimer | Outperform |
| 2024-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-09-08 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-07-07 | Iniziato | ROTH Capital | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-03-26 | Iniziato | Nomura | Buy |
| 2019-04-05 | Iniziato | Jefferies | Buy |
| 2019-03-20 | Iniziato | Oppenheimer | Outperform |
| 2019-01-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-12-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-10-24 | Iniziato | B. Riley FBR | Buy |
| 2018-01-19 | Iniziato | Raymond James | Outperform |
| 2017-12-14 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-11-08 | Reiterato | Noble Financial | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-03-30 | Reiterato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | JMP Securities | Mkt Outperform |
| 2016-11-11 | Reiterato | Noble Financial | Buy |
Mostra tutto
Corbus Pharmaceuticals Holdings Inc Borsa (CRBP) Ultime notizie
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock attracts wealthy investorsEntry Point & Advanced Technical Signal Analysis - Newser
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock trades below fair value2025 Volume Leaders & High Conviction Investment Ideas - Newser
What risks investors should watch in Corbus Pharmaceuticals Holdings Inc. stock2025 AllTime Highs & Intraday High Probability Alerts - Newser
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidate2025 Big Picture & Real-Time Volume Surge Alerts - Newser
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock bottoming after sell offStop Loss & Free Weekly Watchlist of Top Performers - Newser
Behavioral Patterns of CRBP and Institutional Flows - news.stocktradersdaily.com
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock could be top winnerForecast Cut & AI Driven Stock Movement Reports - Newser
Will Corbus Pharmaceuticals Holdings Inc. stock remain a Wall Street favoriteInsider Buying & Technical Confirmation Trade Alerts - Newser
B. Riley Forecasts Lower Earnings for Corbus Pharmaceuticals - MarketBeat
What analysts say about Corbus Pharmaceuticals Holdings Inc 3371 stockSector Performance Drivers & Free Trading Psychology Sessions - earlytimes.in
What is B. Riley’s Forecast for CRBP FY2029 Earnings? - Defense World
(CRBP) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
How interest rate cuts could boost Corbus Pharmaceuticals Holdings Inc. stockPortfolio Performance Summary & Free Long-Term Investment Growth Plans - newser.com
Cannabis Pharmaceuticals Market | Global Market Analysis Report2035 - Fact.MR
Can Corbus Pharmaceuticals Holdings Inc. (3371) stock sustain margin levelsWeekly Gains Summary & High Return Trade Opportunity Guides - newser.com
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top hedge fund pickEarnings Beat & AI Enhanced Trading Signals - newser.com
Can Corbus Pharmaceuticals Holdings Inc. stock surprise with earnings upside2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
What analyst consensus says on Corbus Pharmaceuticals Holdings Inc. stock2025 Technical Overview & Fast Momentum Stock Entry Tips - newser.com
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
How hedge fund analytics apply to Corbus Pharmaceuticals Holdings Inc. stockForecast Cut & Daily Risk Controlled Trade Plans - newser.com
Is it time to cut losses on Corbus Pharmaceuticals Holdings Inc.Quarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock attracts global investors2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a fit for income portfoliosJuly 2025 Reactions & Safe Capital Growth Plans - newser.com
Why Corbus Pharmaceuticals Holdings Inc. stock attracts high net worth investors2025 Dividend Review & Long-Term Growth Portfolio Plans - newser.com
Understanding Corbus Pharmaceuticals Holdings Inc.’s price movementEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Corbus Pharmaceuticals Holdings Inc (3371.BE) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock remain on Wall Street radarPrice Action & Weekly Market Pulse Alerts - newser.com
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):